BUZZ-Sinclair Pharma: surges as possible sale considered

** Sinclair IS Pharma Plc's shares rise as much as 12.4 pct after saying it is evaluating options, including a possible sale.

** Sinclair's shares hit 3-1/2-yr high and among top pct gainers on LSE. Volume busy at 1.27x the 30-day avg in early trade.

** Dermatology and skin care company appoints Rothschild to assist it in evaluating options and says Chairman Grahame Cook will announce strategic review and commencement of offer period to shareholders at the company's annual general meeting later on Tuesday.

** N+1 Singer says while Sinclair's portfolio could "bring substantial value to a potential acquirer".

** N+1 Singer keeps "buy" rating on the stock. Out of the 7 analysts covering Sinclair, 6 have "strong buy" or "buy" rating, according to Thomson Reuters data.